Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proteomic and Functional Studies Reveal Detyrosinated Tubulin as Treatment Target in Sarcomere Mutation-Induced Hypertrophic Cardiomyopathy
Maike Schuldt, Jiayi Pei, Magdaléna Harakaľová, et al.
Circulation Heart Failure (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Altered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy
Sara Ranjbarvaziri, Kristina B. Kooiker, Mathew Ellenberger, et al.
Circulation (2021) Vol. 144, Iss. 21, pp. 1714-1731
Open Access | Times Cited: 182
Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration
Edgar E. Nollet, Inez Duursma, Anastasiya Rozenbaum, et al.
European Heart Journal (2023) Vol. 44, Iss. 13, pp. 1170-1185
Open Access | Times Cited: 53
Enterocyte-like differentiation defines metabolic gene signatures of CMS3 colorectal cancers and provides therapeutic vulnerability
Arezo Torang, Aleksandar B. Kirov, Veerle Lammers, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
MARK4 controls ischaemic heart failure through microtubule detyrosination
Xianjun Yu, Chen Xiao, Mamta Amrute‐Nayak, et al.
Nature (2021) Vol. 594, Iss. 7864, pp. 560-565
Open Access | Times Cited: 78
The microtubule cytoskeleton in cardiac mechanics and heart failure
Matthew A. Caporizzo, Benjamin L. Prosser
Nature Reviews Cardiology (2022) Vol. 19, Iss. 6, pp. 364-378
Open Access | Times Cited: 64
Defects in the Proteome and Metabolome in Human Hypertrophic Cardiomyopathy
Michael J. Previs, Thomas S. O’Leary, Michael P. Morley, et al.
Circulation Heart Failure (2022) Vol. 15, Iss. 6
Open Access | Times Cited: 60
Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working Group on Cellular Biology of the Heart
Jolanda van der Velden, Folkert W. Asselbergs, Jeroen Bakkers, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 15, pp. 3016-3051
Open Access | Times Cited: 55
Sex‐Related Differences in Genetic Cardiomyopathies
Alessia Argirò, Carolyn Y. Ho, Sharlene M. Day, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 9
Open Access | Times Cited: 40
An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy
Bogdan-Sorin Tudurachi, Alexandra Zăvoi, Andreea Leonte, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10510-10510
Open Access | Times Cited: 37
Cardiac myosin contraction and mechanotransduction in health and disease
Samantha K. Barrick, Michael J. Greenberg
Journal of Biological Chemistry (2021) Vol. 297, Iss. 5, pp. 101297-101297
Open Access | Times Cited: 55
The mechanics of the heart: zooming in on hypertrophic cardiomyopathy and cMyBP‐C
Carmen Suay‐Corredera, Jorge Alegre‐Cebollada
FEBS Letters (2022) Vol. 596, Iss. 6, pp. 703-746
Closed Access | Times Cited: 30
Multi-Omic Architecture of Obstructive Hypertrophic Cardiomyopathy
Ramin Garmany, J. Martijn Bos, David J. Tester, et al.
Circulation Genomic and Precision Medicine (2023) Vol. 16, Iss. 2
Open Access | Times Cited: 19
The detyrosination/re-tyrosination cycle of tubulin and its role and dysfunction in neurons and cardiomyocytes
Chadni Sanyal, Niels Pietsch, Sacnicte Ramírez Ríos, et al.
Seminars in Cell and Developmental Biology (2021) Vol. 137, pp. 46-62
Open Access | Times Cited: 41
Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)
Rudolf A. de Boer, Stéphane Heymans, Johannes Backs, et al.
European Journal of Heart Failure (2021) Vol. 24, Iss. 3, pp. 406-420
Open Access | Times Cited: 39
Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy
Carmen Suay‐Corredera, María Rosaria Pricolo, Elías Herrero‐Galán, et al.
Journal of Biological Chemistry (2021) Vol. 297, Iss. 1, pp. 100854-100854
Open Access | Times Cited: 35
Force-sensing protein expression in response to cardiovascular mechanotransduction
Yong-Tao Wang, Emeli Chatterjee, Guoping Li, et al.
EBioMedicine (2024) Vol. 110, pp. 105412-105412
Open Access | Times Cited: 6
Integrative analysis of transcriptome, DNA methylome, and chromatin accessibility reveals candidate therapeutic targets in hypertrophic cardiomyopathy
Junpeng Gao, Mengya Liu, Minjie Lu, et al.
Protein & Cell (2024) Vol. 15, Iss. 11, pp. 796-817
Open Access | Times Cited: 5
Vasohibin inhibition improves myocardial relaxation in a rat model of heart failure with preserved ejection fraction
Deborah Eaton, Benjamin W. Lee, Matthew A. Caporizzo, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 756
Closed Access | Times Cited: 5
Chronic Activation of Tubulin Tyrosination Improves Heart Function
Niels Pietsch, Christina Y. Chen, Svenja Kupsch, et al.
Circulation Research (2024) Vol. 135, Iss. 9, pp. 910-932
Closed Access | Times Cited: 5
Posttranslational modifications of the cytoskeleton
Brittany MacTaggart, Anna Kashina
Cytoskeleton (2021) Vol. 78, Iss. 4, pp. 142-173
Open Access | Times Cited: 31
Cardiomyocyte Microtubules: Control of Mechanics, Transport, and Remodeling
Keita Uchida, Emily A. Scarborough, Benjamin L. Prosser
Annual Review of Physiology (2021) Vol. 84, Iss. 1, pp. 257-283
Open Access | Times Cited: 31
Advances in mechanical biomarkers
Mar Eroles, Félix Rico
Journal of Molecular Recognition (2023) Vol. 36, Iss. 8
Open Access | Times Cited: 13
Targeting mitochondria in hypertrophic cardiomyopathy
Vasco Sequeira, Angelika Batzner, Christoph Maack
European Heart Journal (2023) Vol. 44, Iss. 13, pp. 1186-1188
Closed Access | Times Cited: 12
EGFR/IGF1R Signaling Modulates Relaxation in Hypertrophic Cardiomyopathy
Sıla Algül, Maike Schuldt, Emmy Manders, et al.
Circulation Research (2023) Vol. 133, Iss. 5, pp. 387-399
Open Access | Times Cited: 11
Protein Quality Control Activation and Microtubule Remodeling in Hypertrophic Cardiomyopathy
L. M. Dorsch, Maike Schuldt, Cristobal G. dos Remedios, et al.
Cells (2019) Vol. 8, Iss. 7, pp. 741-741
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top